OAC
PALI icon

OMERS Administration Corp’s Palisade Bio PALI Stock Holding History

OMERS Administration Corp’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$146K Sell
83,300
-24,700
-23% -$44.9K ﹤0.01% 965
2025
Q4 		$254K Buy
+108,000
New +$208K ﹤0.01% 856

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

OMERS Administration Corp's PALI Position: Q1 2026 in Review

OMERS Administration Corp reduced its Palisade Bio (PALI) stake by 23% in Q1 2026, selling an estimated $44.9K and leaving 83,300 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

OMERS Administration Corp first reported a position in PALI in Q4 2025 and has held it in 2 quarters since. The position peaked at $254K in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • OMERS Administration Corp held 83,300 shares of Palisade Bio worth $146K as of Q1 2026.
  • OMERS Administration Corp sold 24,700 Palisade Bio shares in Q1 2026, an estimated $44.9K.
  • Palisade Bio made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #965 holding.
  • OMERS Administration Corp first reported a position in Palisade Bio in Q4 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's Palisade Bio position peaked at $254K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.